Granahan Investment Management NEOLEUKIN THERAP INC ownership

NEOLEUKIN THERAP INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAP INC in Q4 2021. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Granahan Investment Management ownership history of NEOLEUKIN THERAP INC
ValueSharesWeighting
Q3 2021$906
-49.7%
125,331
-35.8%
0.02%
-50.0%
Q2 2021$1,801
-27.0%
195,076
-2.7%
0.03%
-34.6%
Q1 2021$2,468
-28.9%
200,518
-18.6%
0.05%
-33.3%
Q4 2020$3,473
-2.4%
246,299
-16.9%
0.08%
-35.5%
Q3 2020$3,558
-22.0%
296,511
+7.9%
0.12%
-26.7%
Q2 2020$4,562274,8080.16%